7John McPartland. Pathogenicity of Phomopsis ganjae on Cannabis sativa and the fungistatic effect of cannabinoids produced by the host[J] 1984,Mycopathologia(3):149～153
8S. K. Gupta,A. B. Banerjee. Screening of selected West Bengal plants for antifungal activity[J] 1972,Economic Botany(3):255～259
9L. Ferenczy,L. Gracza,I. Jakobey. An antibacterial preparatum from hemp (Cannabis sativa L.)[J] 1958,Die Naturwissenschaften(8):188
6Kreitzer AC, Malenka RC. Endocannabinoid mediated rescue of striatal LTD and motor deficits in Parkinson's disease models [J]. Nature,2007, 2(8):643-647.
7Merritt JC, Perry DD, Russell DN, et al. Topical 9-tetrahydrocannabinol and aqueous dynamics in glaucoma [J]. J Clin Pharmacol, 1981,(21 ):467-471.
8Barrett ML, Scutt AM, Evans FJ. Cannflavin A and B, prenylated flavones from Cannabis sativa L. [J]. Experientia,1986,(42):452-453.
9Radwan MM, Elsohly MA, Slade D, et al. Biologically active cannabinoids from high-potency Cannabis sativa [J]. J Nat Prod,2009,72(5): 906-911.
10Vanhoenacker G, Van Rompaey P, De Keukeleire D, et al. Chemotaxo- nomic features associated with flavonoids of eannabinoid-free Cannabis(Cannabis sativa subsp, sativa L.) in relation to hops (humulus lupulus L.) [J]. Natural Product Letters,2010,16(1):57-63.
